Literature DB >> 28203637

p27kip1: An all-round tumor suppressor.

Barbara Belletti1, Linda Fabris1, Gustavo Baldassarre1.   

Abstract

Our recent study has uncovered an additional mechanism by which the cell cycle inhibitor p27kip1 controls cell proliferation. Through its effect on the activity of the microtubule destabilizing protein Stathmin, p27kip1 modulates full H-Ras activation and, as a consequence, the MAPK signaling cascade. This regulatory mechanism influences the cell cycle in vitro and tissue and/or organ growth in mice, in vivo and, when unbalanced, may lead to uncontrolled proliferation and tumor onset.

Entities:  

Keywords:  Cell cycle; External stimulus; Ras; Stathmin; microtubules; p27kip1

Year:  2016        PMID: 28203637      PMCID: PMC5295474          DOI: 10.1080/23723556.2016.1141742

Source DB:  PubMed          Journal:  Mol Cell Oncol        ISSN: 2372-3556


  10 in total

1.  p27kip1 controls H-Ras/MAPK activation and cell cycle entry via modulation of MT stability.

Authors:  Linda Fabris; Stefania Berton; Ilenia Pellizzari; Ilenia Segatto; Sara D'Andrea; Joshua Armenia; Riccardo Bomben; Monica Schiappacassi; Valter Gattei; Mark R Philips; Andrea Vecchione; Barbara Belletti; Gustavo Baldassarre
Journal:  Proc Natl Acad Sci U S A       Date:  2015-10-28       Impact factor: 11.205

2.  p27(Kip1)-stathmin interaction influences sarcoma cell migration and invasion.

Authors:  Gustavo Baldassarre; Barbara Belletti; Milena S Nicoloso; Monica Schiappacassi; Andrea Vecchione; Paola Spessotto; Andrea Morrione; Vincenzo Canzonieri; Alfonso Colombatti
Journal:  Cancer Cell       Date:  2005-01       Impact factor: 31.743

3.  Cdk2 is dispensable for cell cycle inhibition and tumor suppression mediated by p27(Kip1) and p21(Cip1).

Authors:  Alberto Martín; Junko Odajima; Sarah L Hunt; Pierre Dubus; Sagrario Ortega; Marcos Malumbres; Mariano Barbacid
Journal:  Cancer Cell       Date:  2005-06       Impact factor: 31.743

4.  Cdk5 and its substrates, Dcx and p27kip1, regulate cytoplasmic dilation formation and nuclear elongation in migrating neurons.

Authors:  Yoshiaki V Nishimura; Mima Shikanai; Mikio Hoshino; Toshio Ohshima; Yo-ichi Nabeshima; Ken-Ichi Mizutani; Koh-Ichi Nagata; Kazunori Nakajima; Takeshi Kawauchi
Journal:  Development       Date:  2014-09       Impact factor: 6.868

5.  Feedback regulation of Ras signaling by Rabex-5-mediated ubiquitination.

Authors:  Lizhong Xu; Veronica Lubkov; Laura J Taylor; Dafna Bar-Sagi
Journal:  Curr Biol       Date:  2010-07-22       Impact factor: 10.834

Review 6.  p27(kip1) functional regulation in human cancer: a potential target for therapeutic designs.

Authors:  B Belletti; M S Nicoloso; M Schiappacassi; E Chimienti; S Berton; F Lovat; A Colombatti; G Baldassarre
Journal:  Curr Med Chem       Date:  2005       Impact factor: 4.530

Review 7.  The ERK1/2 mitogen-activated protein kinase pathway as a master regulator of the G1- to S-phase transition.

Authors:  S Meloche; J Pouysségur
Journal:  Oncogene       Date:  2007-05-14       Impact factor: 9.867

8.  SUMOylation regulates p27Kip1 stability and localization in response to TGFβ.

Authors:  Sara Lovisa; Simona Citro; Maura Sonego; Alessandra Dall'Acqua; Valentina Ranzuglia; Stefania Berton; Alfonso Colombatti; Barbara Belletti; Susanna Chiocca; Monica Schiappacassi; Gustavo Baldassarre
Journal:  J Mol Cell Biol       Date:  2015-10-08       Impact factor: 6.216

9.  Contact inhibition modulates intracellular levels of miR-223 in a p27kip1-dependent manner.

Authors:  Joshua Armenia; Linda Fabris; Francesca Lovat; Stefania Berton; Ilenia Segatto; Sara D'Andrea; Cristina Ivan; Luciano Cascione; George A Calin; Carlo M Croce; Alfonso Colombatti; Andrea Vecchione; Barbara Belletti; Gustavo Baldassarre
Journal:  Oncotarget       Date:  2014-03-15

10.  Genetic characterization of p27(kip1) and stathmin in controlling cell proliferation in vivo.

Authors:  Stefania Berton; Ilenia Pellizzari; Linda Fabris; Sara D'Andrea; Ilenia Segatto; Vincenzo Canzonieri; Daniela Marconi; Monica Schiappacassi; Sara Benevol; Valter Gattei; Alfonso Colombatti; Barbara Belletti; Gustavo Baldassarre
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.